NCT04970212
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Drug Category: Other
Key Eligibility Criteria:
Gender: All
Age: 21 Years and older (Adult, Older Adult)
Location of Metastases: Liver
Additional Notes: Patient must be scheduled for liver tissue ablation
Exclusions:
https://ClinicalTrials.gov/show/NCT04970212